General Announcement::SINOPHARM COVID-19 VACCINE TO BE ADMINISTERED IN ASIAMEDIC CLINICS FROM 30 SEPTEMBER 2021

ASIAMEDIC LIMITED

(Incorporated in the Republic of Singapore)

(Registration No. 197401556E)

SINOPHARM COVID-19 VACCINE TO BE ADMINISTERED IN ASIAMEDIC CLINICS

FROM 30 SEPTEMBER 2021

The board of directors (the "Board" or the "Directors") of AsiaMedic Limited (the "Company" and, together with its subsidiaries, the "Group") is pleased to announce that the Group's clinics, namely AsiaMedic Wellness Assessment Centre Pte Ltd and Complete Healthcare International Pte Ltd (collectively, the "Clinics"), have obtained the Special Access Route (the "SAR") approvals from the Health Sciences Authority of Singapore (the "HSA") to import and administer the Sinopharm COVID-19 Vaccine (the "Vaccine"). This approval is valid for a period of 6 months from 29 September 2021. The Group will be procuring the Vaccine from a HSA-licensed importer.

The Vaccine will be administered at the Clinics from Thursday, 30 September 2021. Further details are as follows:

	Name of Clinic		Address		Appointment Booking	Contact Details
					Methods
	AsiaMedic Wellness		350 Orchard Road			6789 8888
	Assessment Centre	#08-00		Google Form:
	Pte Ltd		Shaw House
			Singapore 238868		https://docs.google.com/forms/d
					/1gfQCVz3I7ZBiXE1MCKtneybf
					CfkHyWR06JD71ZIJw9c/viewfo
					rm?edit_requested=true
	Complete Healthcare		350 Orchard Road		6776 2288
	International Pte Ltd	#10-01
			Shaw House		Email:
			Singapore 238868
					[e-mail]

The offering of the Vaccine is part of the Group's initiatives to support the fight against the COVID-19 pandemic in Singapore. Other efforts include providing Antigen Rapid Test (ART), Polymerase Chain Reaction (PCR) tests and pre-departure testing (PDT) services at the Clinics.

The Group is not able to quantify the financial effects under this initiative as the take-up rate for the Vaccine cannot be reasonably determined as at the date of this announcement.

BY ORDER OF THE BOARD

Foo Soon Soo (Ms)

Company Secretary

30 September 2021

1

This announcement has been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd, in compliance with Rule 226 of the Rules of Catalist. It has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Pauline Sim (Registered Professional) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 6319 4954.

2